News

Bharat Biotechs intra-nasal Covid-19 vaccine receives approval for emergency use in India

Hyderabad/UNI: Bharat Biotech International Limited (BBIL) Tuesday announced that iNCOVACC (BBV154), its intra-nasal vaccine against Covid-19, has received approval under restricted use in an emergency situation for ages 18 and above in India.

by India Blooms News Service September 06, 2022